ABILIFY 1 mg/mL oral solution

Company
Otsuka Pharmaceutical UK Ltd.
Active Ingredient
Dosage Form
Oral solution
Legal Category
B - prescription, may be renewed

*further information is available on request to the holder of the authorisation or in the SPC

Loading the document

Otsuka Pharmaceutical UK Ltd.

Otsuka Pharmaceuticals (U.K.) Ltd., 2 Windsor Dials, Arthur Road, Windsor SL4 1RS, United Kingdom

Email
medical.information@otsuka-europe.com